Consumer Decision-Making and Ophthalmic Conditions: A Novel Area of Marketing Research.

Orthotopic heart transplantation (HTx) has been established as the gold standard for the management of advanced heart failure []. Major progress in pretransplant evaluation, perioperative management, immunosuppression, and long-term follow-up has markedly improved outcomes, with contemporary median survival now approaching 12.5 years in many adult cohorts []. Improving long-term survival has naturally expanded the goals of transplant care to include patients’ well-being in daily life. As a result, quality of life (QoL) has become one of the central considerations in evaluating the overall success of HTx, reflecting the understanding that survival alone does not fully capture the full spectrum of posttransplant health domains []. QoL is a multidimensional entity encompassing physical health, psychological well-being, social functioning, and treatment-related considerations []. Each of these dimensions may be significantly influenced by the transplant procedure itself and by the lifelong immunosuppressive therapy that follows. In recent years, psychological and emotional outcomes, particularly symptoms of anxiety and depression, have become integral components of comprehensive posttransplant evaluation because of their impact on adherence, coping, and long-term adjustment []. Numerous studies have demonstrated that QoL typically improves substantially after transplantation [-]. Although overall gains are well documented, the pace and extent of recovery vary across different domains of health. Physical capacity, emotional stability, social functioning, and treatment-related burden do not improve uniformly, and each may regain preillness or near-normal levels at different rates following surgery []. These variations are clinically meaningful, as trajectories in a specific QoL domain can influence long-term adjustment and may even contribute to differences in survival. Furthermore, QoL does not follow a single pattern for all individuals. Differences in follow-up duration, age at transplantation, and gender contribute to distinct recovery profiles, each with implications for long-term care and patient support.